FBR Capital Upgrades AMAG Pharmaceuticals To Outperform By: Benzinga via Benzinga September 30, 2014 at 08:19 AM EDT Analysts at FBR Capital upgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Market Perform to Outperform. The target price for AMAG ... Read More >> Related Stocks: Amag Pharmaceuticals